Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Bitsaktsis

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infectionConstantine Bitsaktsis, Gary Winslow
Current Opinion in Infectious Diseases|May 3, 2005
Immunity to the ehrlichiae: new tools and recent developmentsGary M Winslow, Constantine Bitsaktsis
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infectionConstantine Bitsaktsis, Jennifer Huntington, Gary Winslow
Journal of Neurovirology|February 1, 2014
Reactivation of human polyomaviruses in immunocompromised statesKari Wiedinger, Constantine Bitsaktsis, Sulie Chang
Vaccine|July 11, 2020
Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infectionKari Wiedinger, James McCauley, Constantine Bitsaktsis
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 29, 2020
Macrophage subtype and cytokine expression characterization during the acute inflammatory phase of mouse bone fracture repairJames McCauley, Constantine Bitsaktsis, Jessica Cottrell
Therapeutic Advances in Vaccines|December 16, 2015
Cholera toxin B induced activation of murine macrophages exposed to a fixed bacterial immunogenKari Wiedinger, Heather Romlein, Constantine Bitsaktsis
Therapeutic Advances in Vaccines|March 28, 2017
Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against <i>S. pneumoniae</i> infection in miceKari Wiedinger, Daniel Pinho, Constantine Bitsaktsis
Annals of the New York Academy of Sciences|February 17, 2006
Susceptibility and resistance to monocytic ehrlichiosis in the mouseGary M Winslow, Constantine Bitsaktsis, Eric Yager
Infection and Immunity|October 15, 2014
In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge modelConstantine Bitsaktsis, Zulfia Babadjanova, Edmund J Gosselin
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infectionConstantine Bitsaktsis, Gary Winslow
Current Opinion in Infectious Diseases|May 3, 2005
Immunity to the ehrlichiae: new tools and recent developmentsGary M Winslow, Constantine Bitsaktsis
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infectionConstantine Bitsaktsis, Jennifer Huntington, Gary Winslow
Journal of Neurovirology|February 1, 2014
Reactivation of human polyomaviruses in immunocompromised statesKari Wiedinger, Constantine Bitsaktsis, Sulie Chang
Vaccine|July 11, 2020
Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infectionKari Wiedinger, James McCauley, Constantine Bitsaktsis
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 29, 2020
Macrophage subtype and cytokine expression characterization during the acute inflammatory phase of mouse bone fracture repairJames McCauley, Constantine Bitsaktsis, Jessica Cottrell
Therapeutic Advances in Vaccines|December 16, 2015
Cholera toxin B induced activation of murine macrophages exposed to a fixed bacterial immunogenKari Wiedinger, Heather Romlein, Constantine Bitsaktsis
Therapeutic Advances in Vaccines|March 28, 2017
Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against <i>S. pneumoniae</i> infection in miceKari Wiedinger, Daniel Pinho, Constantine Bitsaktsis
Annals of the New York Academy of Sciences|February 17, 2006
Susceptibility and resistance to monocytic ehrlichiosis in the mouseGary M Winslow, Constantine Bitsaktsis, Eric Yager
Infection and Immunity|October 15, 2014
In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge modelConstantine Bitsaktsis, Zulfia Babadjanova, Edmund J Gosselin
Pageof 3